AMBROSIA BIO has developed a disruptive, evolutionary enzyme technology platform that is used to design superior enzymes to convert obesity-promoting industrial sugars into minimal-calorie rare sugars. AMBROSIA BIO’s B2B business model will provide the leading sugar & juice manufacturers the opportunity to meet customer expectations of sugar reduction without affecting the consumption experience. AMBROSIA BIO will deliver tailored (Plug and Play) engineering solutions for its partners to meet surging Allulose demand.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Nahal Snir 15, Yavne, Yavne,central 8122451,israel
- Industry
- Biotechnology
- Website
- http://www.ambrosia.bio
- Keywords
- Kfar Saba.
- HQ
- Yavne, Central
Ambrosia Bio Questions
Ambrosia Bio's website is http://www.ambrosia.bio
Ambrosia Bio's LinkedIn profile is https://il.linkedin.com/company/ambrosia-bio
Ambrosia Bio has
6 employees.
View email and phone details for 6
employees at Ambrosia Bio.
Ambrosia Bio's industry is
Biotechnology
Ambrosia Bio's top competitors are
Borealis Biosciences, Inc.,
Pepticom Ltd.,
Biogiv,
Neomanna - Next Generation Insect-Derived Antimicrobials,
Diptera.ai,
Vital Technologies Ltd.,
Ambrosia Biosciences Inc.,
Aleph Farms,
Photonpharma,
Seprosys.
Ambrosia Bio's categories are Biotechnology
Ambrosia Bio's founding year is 2020
